Jay Achar

Standardised shorter regimens <i>versus</i> individualised longer regimens for rifampin- or multidrug-resistant tuberculosis

S.K. Abidi, Jay Achar, M.M. Assao Neino et al. · European Respiratory Journal · 2019 · 88 citations · Full text

Public Health, Pharmacotherapy, Clinical Epidemiology +16

Prognostic Indicators for Ebola Patient Survival

Samuel J. Crowe, Matthew J. Maenner, Solomon Kuah et al. · Emerging infectious diseases · 2015 · 59 citations · Full text

Medicine, Infectious Diseases, Clinical Epidemiology +9

Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis

Jay Achar, Cathy Hewison, Ana P. Cavalheiro et al. · Emerging infectious diseases · 2017 · 53 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Inpatient signs and symptoms and factors associated with death in children aged 5 years and younger admitted to two Ebola management centres in Sierra Leone, 2014: a retrospective cohort study

Tejshri Shah, Jane Greig, Linda Margaretha van der Plas et al. · The Lancet Global Health · 2016 · 36 citations · Full text

Public Health, Infectious Diseases, Pediatrics +15

Global impact of COVID-19 on childhood tuberculosis: an analysis of notification data

Lasith Ranasinghe, Jay Achar, Matthias I. Gröschel et al. · The Lancet Global Health · 2022 · 33 citations · Full text

Public Health, Child Health, Infectious Diseases +17